4.5 Article

25-hydroxyvitamin D3 status is associated with developing adaptive and innate immune responses in the first 6 months of life

期刊

CLINICAL AND EXPERIMENTAL ALLERGY
卷 45, 期 1, 页码 220-231

出版社

WILEY
DOI: 10.1111/cea.12449

关键词

25(OH)D3; allergens; allergic disease; cord blood; cytokines; eczema; Toll-like receptor; Vitamin D

资金

  1. National Health and Medical Research Council (NHMRC) of Australia [458502]
  2. NHMRC

向作者/读者索取更多资源

BackgroundVitamin D (25[OH]D3) status in early life has been linked to the risk of allergic disease in multiple observational studies. While immunomodulating properties are well recognized, there are few longitudinal studies of 25(OH)D3 status, immune function and allergic disease in infants. ObjectiveTo investigate 25(OH)D3 levels at birth [cord blood (CB)] and at 6months of age in relation to immune function at 6months of age, and clinical outcomes up to 30months of age in infants with a maternal history of atopy. MethodsIn a subset of infants (n=225) enrolled in a RCT (ACTRN12606000281594), 25(OH)D3 levels were assessed in relation to peripheral blood mononuclear cell cytokine responses to house dust mite (HDM), ovalbumin (OVA) and -lactoglobulin allergens, or Toll-like receptor (TLR) ligands (lipopolysaccharide, lipoteichoic acid, polyinosinic:polycytidylic acid and CpG oligonucleotide) at 6months of age, in addition to clinical outcomes (eczema, wheeze and allergen sensitisation) up to 30months of age. ResultsInfants with higher 25(OH)D3 at birth (75nmol/L, compared with <50nmol/L) had lower IL-5 and IL-13 responses to HDM by 6months (P<0.001 and P=0.003, respectively). This was also reflected in strong inverse correlations between CB 25(OH)D3 levels and HDM IL-13 (=-0.57; P=0.0002) and IL-5 (=-0.59, P=0.0001) responses, with a similar trend for IL-5 (=-0.29; P=0.009) responses to OVA. For innate stimulations, higher 25(OH)D3 levels at 6months were associated with greater responses to TLR ligands. Additionally, higher CB 25(OH)D3 was associated with reduced risk eczema at 6months (P=0.011) and 12months (P=0.034). ConclusionThis suggests that improving 25(OH)D3 status in pregnancy or early infancy may reduce the development of allergic disease in high-risk infants by inhibiting cytokine profiles associated with allergy. Results of clinical trials are awaited to determine the efficacy of vitamin D supplementation in allergy prevention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据